`
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_________________
`
`PROLLENIUM US INC.
`
`Petitioner
`
`v.
`
`ALLERGAN INDUSTRIE, SAS
`
`Patent Owner
`
`_________________
`
`DEPOSITION OF DALE P. DEVORE, PhD
`
` Wednesday, August 12, 2020 - 9:00 a.m.
`
`Veritext Legal Solutions
`
`101 Arch Street
`
`Boston, Massachusetts
`
`Job no. 4198539
`
`Reported by: Jill K. Ruggieri, RPR, RMR, FCRR, CRR
`
`Pages 1 - 316
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 1
`
`1
`
`2
`
`3
`
`4 5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`ALL 2100
`PROLLENIUM V. ALLERGAN
`IPR2019-01505 et al.
`
`
`
`A P P E A R A N C E S :
`
`M e u n i e r C a r l i n & C u r f m a n L L C
`
` W a r r e n J . T h o m a s , E s q .
`
` 9 9 9 P e a c h t r e e S t r e e t , N E , S u i t e 1 3 0 0
`
` A t l a n t a , G e o r g i a 3 0 3 0 9
`
` 4 0 4 . 6 4 5 . 7 7 0 0
`
` w t h o m a s @ m c c i p l a w . c o m
`
` C o u n s e l f o r p e t i t i o n e r
`
`J o n e s D a y
`
` S . C h r i s t i a n P l a t t , E s q .
`
` S a r a h G e e r s , E s q . ( v i a Z o o m )
`
` J e n n i f e r H a r t j e s , E s q . ( v i a Z o o m )
`
` 4 6 5 5 E x e c u t i v e D r i v e , S u i t e 1 5 0 0
`
` S a n D i e g o , C a l i f o r n i a 9 2 1 2 1 - 3 1 3 4
`
` 8 5 8 . 3 1 4 . 1 2 0 0
`
` c p l a t t @ j o n e s d a y . c o m
`
` s g e e r s @ j o n e s d a y . c o m
`
` j h a r t j e s @ j o n e s d a y . c o m
`
` C o u n s e l f o r p a t e n t o w n e r
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`1 0
`
`1 1
`
`1 2
`
`1 3
`
`1 4
`
`1 5
`
`1 6
`
`1 7
`
`1 8
`
`1 9
`
`2 0
`
`2 1
`
`2 2
`
`2 3
`
`2 4
`
`2 5
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 2
`
`
`
`A l s o p r e s e n t ( v i a Z o o m ) : L i n d a F r i e d l i e b
`
` R y a n C o l e t t i
`
` J o h n H a r b i n
`
` A n t h o n y Z u c c h e r o
`
`V i d e o g r a p h e r : A n t h o n y P i c c i r i l l i
`
`1
`
`2
`
`3
`
`4
`
`5 6
`
`7 8 9
`
`1 0
`
`1 1
`
`1 2
`
`1 3
`
`1 4
`
`1 5
`
`1 6
`
`1 7
`
`1 8
`
`1 9
`
`2 0
`
`2 1
`
`2 2
`
`2 3
`
`2 4
`
`2 5
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 3
`
`
`
` I N D E X
`
`WITNESS:
`
`DALE P. DEVORE, PhD.
`
` Examination by Mr. Platt 8
`
` E X H I B I T S
`
` Exhibit 58 Base structure of the 57
`
` units in hyaluronic acid
`
` Exhibit 64 Two pages of chemical 60
`
` structures
`
` Exhibit 1 Document re: 1.6 percent 65
`
` sodium HA
`
` Exhibit 33 Part of the FDA document 81
`
` for PMA approval
`
` Exhibit 2 Document 88
`
` Exhibit 60 Anika Therapeutics Form 122
`
` 10-Q, 3/31/04
`
` Exhibit 4 Document re: Class 3 131
`
` device recall
`
` Exhibit 46 US Patent No. 10,463,595 147
`
` Exhibit 48 Viscoelastic Evaluation of 153
`
` Different Hyaluronic Acid
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 4
`
`1
`
`2 3
`
`4 5
`
`6
`
`7 8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` Based Fillers Using
`
` Vibrational Optical
`
` Coherence Tomography
`
` Exhibit 27 June 2017 abstract from 173
`
` the ARVO Annual Meeting
`
` Exhibit 10 US Patent No. 6,946,551 187
`
` Exhibit 28 US Patent No. 9,352,046 196
`
` Exhibit 35 Mentor Reports 224
`
` Third-Quarter Financial
`
` Results
`
` Exhibit 36 Form 10-Q by Mentor 226
`
` Corporation
`
` Exhibit 37 Mentor Corporation, 227
`
` 3/31/2006
`
` Exhibit 38 Mentor Corporation 10-K, 229
`
` 3/31/2007
`
` Exhibit 39 Mentor Corporation 10-K, 231
`
` 3/31/2008
`
` Exhibit 5 Anika Form 10-K, 12/2006 244
`
` Exhibit 22 Printout from the FDA for 247
`
` a PMA supplement
`
` Exhibit 23 PMA supplement 249
`
` Exhibit 6 Supplemental PMA, 1/4/2008 250
`
` Exhibit 29 DeVore declaration in EMS 275
`
` Exhibit 41 Expert Report by Dr. Dale 282
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 5
`
`
`
` P. DeVore in the United
`
` States District Court,
`
` Central District of
`
` California, Southern
`
` Division
`
` Exhibit 3 US Patent, 4,920,104 314
`
` Exhibit 13 US Patent 4,716,224 314
`
` Exhibit 14 US Patent 5,099,013 314
`
` Exhibit 20 BioCell District Court 314
`
` order
`
` Exhibit 30 BioCell DeVore CV 314
`
` Exhibit 40 DeVore ITC CV 314
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 6
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` P R O C E E D I N G S 08:55:23
`
` THE VIDEOGRAPHER: Good 08:58:38
`
`morning. We are now on the record. Please 08:58:39
`
`note that the microphones are sensitive and 08:58:40
`
`may pick up whispering and private 08:58:42
`
`conversations. Please turn off all 08:58:44
`
`cellphones or place them away from the 08:58:46
`
`microphones, as they can interfere with the 08:58:48
`
`deposition audio. 08:58:51
`
` Recording will continue until all 08:58:52
`
`parties agree to go off the record. 08:58:55
`
` My name is Anthony Piccirilli, 08:58:57
`
`representing Veritext. The date today is 08:58:59
`
`August 12, 2020, and the time is approximately 08:59:02
`
`9:00 a.m. This deposition is being held at 101 08:59:06
`
`Arch Street in Boston, Massachusetts. 08:59:10
`
` The caption of this cases is 08:59:13
`
`Prollenium US versus Allergan Industrie SAS. 08:59:15
`
`The name of the witness is Dale DeVore. 08:59:20
`
` At this time, the attorneys 08:59:23
`
`present in the room and everyone attending 08:59:24
`
`remotely will identify themselves and the 08:59:26
`
`parties they represent, after which our court 08:59:30
`
`reporter, Jill Ruggieri, representing Veritext, 08:59:32
`
`will swear in the witness, and we can proceed. 08:59:35
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 7
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` MR. PLATT: Christian Platt 08:59:38
`
`from Jones Day on behalf of the patent owner, 08:59:40
`
`Allergan, and also with me remotely, also 08:59:42
`
`from Jones Day, is Sarah Geers, as well as 08:59:48
`
`Jennifer Hartjes. Also joining remotely from 08:59:52
`
`the patent owner are in-house counsel Linda 08:59:56
`
`Friedlieb and Ryan Coletti. 09:00:00
`
` MR. THOMAS: And I'm Warren 09:00:06
`
`Thomas for the petitioner, Prollenium US, 09:00:07
`
`Inc., from the law firm Meunier Carlin & 09:00:10
`
`Curfman. Attending remotely from MCC for 09:00:11
`
`Prollenium US, Inc. are John Harbin and 09:00:16
`
`Anthony Zucchero. 09:00:18
`
` 09:00:21
`
` DALE P. DEVORE, PhD, a witness 09:00:21
`
`having been duly sworn, on oath deposes and 09:00:21
`
`says as follows: 09:00:21
`
` 09:00:21
`
` EXAMINATION 09:00:21
`
`BY MR. PLATT: 09:00:32
`
` Q Good morning, Dr. DeVore. 09:00:34
`
` A Good morning. 09:00:36
`
` Q Could you please just state your 09:00:37
`
`name for us. 09:00:38
`
` A Dale Paul DeVore. 09:00:40
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 8
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` Q And you've taken an oath to tell 09:00:43
`
`the truth today, correct? 09:00:45
`
` A Yes. 09:00:46
`
` Q And you understand that because 09:00:47
`
`this is a Patent Office procedure, there's 09:00:49
`
`also a duty of candor that applies to that? 09:00:53
`
` A Yes. 09:00:56
`
` Q Okay. 09:00:56
`
` You understand a transcript of 09:00:56
`
`the proceedings is being taken down, and that 09:00:58
`
`will be supplied to the judges that are 09:01:01
`
`hearing this IPR matter; is that right? 09:01:02
`
` A Yes. 09:01:07
`
` Q Now, I'll be asking you a series of 09:01:08
`
`questions. If you don't understand those 09:01:10
`
`questions, can you ask me for clarification? 09:01:14
`
` A Yes. 09:01:18
`
` Q And if you don't ask for 09:01:19
`
`clarification, can we assume that you 09:01:20
`
`understood the question? 09:01:22
`
` A Yes. 09:01:25
`
` Q Now, you understand that Mr. Thomas 09:01:26
`
`may make objections, but unless you're 09:01:29
`
`instructed otherwise, you need to answer the 09:01:33
`
`question. 09:01:35
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 9
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` Do you understand that? 09:01:36
`
` A Yes. 09:01:36
`
` Q For example, you understand that 09:01:37
`
`you can't refuse to answer a question on 09:01:38
`
`confidentiality grounds? You understand 09:01:40
`
`that? 09:01:42
`
` A Yes. 09:01:43
`
` Q Now, is there any reason today why 09:01:46
`
`you can't give us complete, accurate and 09:01:50
`
`truthful testimony? 09:01:53
`
` A No reason I can't. 09:01:54
`
` Q And have you given sworn testimony 09:01:56
`
`in the past in the form of a deposition? 09:02:00
`
` A As a technical individual for -- 09:02:04
`
`not like this one. 09:02:07
`
` Q Have you given a deposition in 09:02:09
`
`other cases, whether in court or in the 09:02:13
`
`Patent Office? 09:02:17
`
` A Not in court. 09:02:17
`
` Q Okay. 09:02:18
`
` Have you had a deposition 09:02:18
`
`before like in this format, where there's a 09:02:19
`
`court reporter taking down the words -- 09:02:23
`
` A Yes. 09:02:25
`
` Q Okay. 09:02:25
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 10
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` So you're a little bit 09:02:25
`
`familiar with the process? 09:02:27
`
` A A little bit. 09:02:30
`
` Q So just for some reminders, we'll 09:02:31
`
`go through that a little bit. We'll go for 09:02:34
`
`about an hour today, and then we'll take a 09:02:37
`
`short break, and if at any time during the 09:02:41
`
`proceeding you need a break, use the 09:02:46
`
`restroom, something like that, just let us 09:02:48
`
`know. 09:02:49
`
` The only thing I would ask is 09:02:50
`
`normally we'd ask that you answer the 09:02:51
`
`question before we take a break. 09:02:53
`
` A Yes, I understand. 09:02:55
`
` Q The other thing is that our court 09:02:57
`
`reporter is going to be taking down 09:03:00
`
`everything that we're saying, so we need to 09:03:01
`
`be cautious not to talk over one another. 09:03:03
`
` Do you understand that? 09:03:07
`
` A I understand that. 09:03:08
`
` Q The other thing is, we'll be 09:03:09
`
`looking for affirmative answers, so 09:03:10
`
`"mm-hmms," "uh-uhs" are difficult to keep 09:03:12
`
`track of, so if you can answer "yes," "no," 09:03:19
`
`using language like that. 09:03:21
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 11
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` A Yes. 09:03:22
`
` Q Understood? 09:03:23
`
` Now, you understand that 09:03:25
`
`you've offered declarations in support of a 09:03:27
`
`number of IPR petitions filed in the Patent 09:03:31
`
`Trial and Appeal Board; is that right? 09:03:35
`
` A Yes. 09:03:38
`
` Q And the IPR petitions that we'll be 09:03:39
`
`talking about today are for IPR2019-01505, 09:03:40
`
`01506, 01508, 01509, 01617, 01623 and 09:03:49
`
`2020-00084; is that right? 09:04:02
`
` A That's right. 09:04:08
`
` Q And you understand you're here to 09:04:08
`
`testify both today and tomorrow on those -- 09:04:10
`
`on your declarations in those IPR petitions? 09:04:13
`
` A Yes. 09:04:19
`
` Q Now, we also have -- there's a 09:04:19
`
`number of patents that are at issue there. I 09:04:21
`
`think there's seven IPR petitions. There's 09:04:23
`
`six patents at issue. 09:04:26
`
` You understand that it's -- 09:04:27
`
`that in referring to patents, it's fairly 09:04:29
`
`common to refer to the last three digits of 09:04:32
`
`the patent number? 09:04:34
`
` A Yes. 09:04:36
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 12
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` Q So if we refer to the last three 09:04:36
`
`digits, you'll understand which patent number 09:04:38
`
`we're talking about? Is that right? 09:04:39
`
` A Yes. 09:04:42
`
` Q So I have placed a number of 09:04:43
`
`binders in front of you, and we've tried to 09:04:48
`
`premark everything so that we don't have to 09:04:53
`
`exchange exhibits. 09:04:56
`
` And I do want to say thanks to 09:04:58
`
`everybody here for going through this process 09:05:01
`
`in the pandemic. So we've tried to make it 09:05:03
`
`in such a way so that we're not having to 09:05:05
`
`pass documents back and forth to each other. 09:05:08
`
` So they're all there. They've 09:05:10
`
`been sitting there since yesterday, and I 09:05:11
`
`will give you just a brief summary of what 09:05:15
`
`those are in front of you. 09:05:18
`
` So first off, on the 09:05:19
`
`right-hand side, there's two white binders 09:05:20
`
`there. Those two white binders contain the 09:05:23
`
`exhibits that have already been marked in the 09:05:25
`
`Patent Office. So that's the 1000 series 09:05:27
`
`exhibits as well as some of the 2000 series, 09:05:30
`
`and then the 3000 series as well. 09:05:33
`
` A Yes. 09:05:36
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 13
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` Q In front of you is a green binder 09:05:36
`
`that has your declarations in it. We've 09:05:39
`
`included all seven of the declarations in the 09:05:42
`
`IPRs that have been filed. We also included 09:05:44
`
`in there, there are two additional 09:05:48
`
`declarations that have been submitted. This 09:05:52
`
`deposition is not about those two additional 09:05:54
`
`IPRs, the 901 and 902, I believe, but they're 09:05:57
`
`in there just in case we need to refer to it 09:06:00
`
`for a couple questions just regarding your 09:06:03
`
`testimony in these seven IPRs, okay? 09:06:05
`
` A Okay. 09:06:09
`
` Q On the left-hand side are a series 09:06:09
`
`of pink binders, and those are documents that 09:06:13
`
`will be used as exhibits today in the 09:06:16
`
`deposition. 09:06:20
`
` Per my discussion with 09:06:20
`
`Prollenium's counsel, those documents are to 09:06:22
`
`be left in the room. Mr. Thomas has agreed 09:06:26
`
`that he's not going to flip through them and 09:06:32
`
`do a preview of what the exhibits may be, but 09:06:34
`
`each one of those has a tab on it 09:06:38
`
`corresponding to the document or exhibit 09:06:39
`
`number that we'll be using, so I may refer to 09:06:41
`
`those and say let's take a look at this 09:06:45
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 14
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`particular exhibit. It's going to be in the 09:06:47
`
`pink binder. 09:06:49
`
` A All right. 09:06:49
`
` Q And then on the floor next to you 09:06:52
`
`then are a series of additional binders. And 09:06:54
`
`there is a yellow binder with the institution 09:06:58
`
`decisions in there. There is a blue binder 09:07:01
`
`with all of the patents that are at issue 09:07:05
`
`among the IPR petitions. And then there is a 09:07:07
`
`white binder containing the IPR petitions 09:07:10
`
`filed by Prollenium's counsel. 09:07:14
`
` So I think I've covered all 09:07:16
`
`the potential documents that may be in here, 09:07:17
`
`but I wanted to make sure that that's on the 09:07:21
`
`record so we know if we're referring to, for 09:07:23
`
`example, I say take a look at the green 09:07:26
`
`binder, that's your declarations. 09:07:29
`
` A Mm-hmm. 09:07:31
`
` Q So any questions for me about that? 09:07:32
`
` A No. 09:07:35
`
` Q Okay. 09:07:36
`
` MR. PLATT: And I would add, 09:07:36
`
`the other thing that we've agreed to between 09:07:38
`
`counsel -- and Warren, correct me if I'm 09:07:41
`
`wrong here, if I don't state it correctly -- 09:07:44
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 15
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`but with the pink binder, the documents for 09:07:45
`
`the exhibits today, again, those are going to 09:07:48
`
`be left in the room. At the end of the 09:07:51
`
`deposition, we will pull out any of the 09:07:53
`
`exhibits that we did not use during the 09:07:54
`
`deposition, and then you'll be free to take 09:07:56
`
`those with you. 09:07:59
`
` MR. THOMAS: Yes, understood 09:08:00
`
`and agreed by petitioners. 09:08:01
`
` Q So let's take a look at your 09:08:06
`
`declaration. So that's going to be the green 09:08:10
`
`binder in front of you. 09:08:13
`
` A Mm-hmm. 09:08:17
`
` Q And with respect to the 09:08:17
`
`declarations you've submitted in this case, 09:08:21
`
`are there any corrections that you'd like to 09:08:23
`
`make? 09:08:25
`
` A Maybe one typographical correction, 09:08:28
`
`but not really. 09:08:31
`
` Q And what is that? 09:08:32
`
` A I have to go back and look again. 09:08:34
`
` Q Sure. Please do. And let me 09:08:36
`
`know -- 09:08:37
`
` A I think the identification of 09:08:38
`
`bio -- carbodiimide, we originally had BCDI 09:08:40
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 16
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`and we changed that to the correct name. 09:08:49
`
` Q Okay. 09:08:51
`
` A That's it. 09:08:51
`
` Q And we can talk about that later. 09:08:51
`
` Any other corrections that you 09:08:55
`
`want to make in your declarations? 09:08:56
`
` A Not at the present, no. 09:08:58
`
` Q And were your declarations accurate 09:08:59
`
`when you signed them? 09:09:01
`
` A Yes. 09:09:02
`
` Q And were there any 09:09:04
`
`misrepresentations made in your declarations? 09:09:06
`
` A No. 09:09:10
`
` Q Now, when were you first contacted 09:09:15
`
`to work on these IPR matters? 09:09:20
`
` A Originally contacted by Prollenium 09:09:22
`
`in August of 2018. 09:09:24
`
` Q And who contacted you? 09:09:28
`
` A The president, Ario. I can't think 09:09:34
`
`of his last name right now. 09:09:39
`
` Q The president of Prollenium? 09:09:41
`
` A The president of Prollenium. 09:09:43
`
` Q And did you know the president of 09:09:43
`
`Prollenium prior to that? 09:09:45
`
` A Yes, I did. 09:09:46
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 17
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` Q And how is that that you know him? 09:09:47
`
` A Well, at one point, they were 09:09:49
`
`looking for someone to help them with their 09:09:50
`
`development, and they had asked me if I was 09:09:54
`
`interested, but I was already associated with 09:09:56
`
`my own company. 09:09:59
`
` Q And when you say looking for 09:10:03
`
`development, they were interested in -- what 09:10:04
`
`do you mean by that? 09:10:09
`
` A They were interested in someone to 09:10:10
`
`handle the risk -- research and development. 09:10:11
`
` Q And then what happened -- what 09:10:21
`
`happened after that? At some point were you 09:10:23
`
`contacted regarding these -- 09:10:25
`
` A Well, I suggested someone else who 09:10:27
`
`I knew who took the position. 09:10:29
`
` Q And did you know the president 09:10:33
`
`prior to this call? 09:10:35
`
` MR. THOMAS: Objection to 09:10:38
`
`form. 09:10:38
`
` Q Did you have a personal 09:10:43
`
`relationship with the president prior to 09:10:44
`
`this? 09:10:45
`
` A No, no. 09:10:46
`
` Q You hadn't worked with him -- 09:10:46
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 18
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` A No, I haven't worked with him, no. 09:10:48
`
` Q And when were you contacted 09:10:50
`
`regarding your work with respect to the 09:10:51
`
`declarations that were submitted in these IPR 09:10:53
`
`petitions? 09:10:55
`
` A It was in August of 2018. I don't 09:10:56
`
`remember the exact date. 09:10:58
`
` Q I'm trying to -- hopefully you can 09:11:01
`
`help me understand this. 09:11:02
`
` I understood you to be saying 09:11:04
`
`you were contacted relating to doing some 09:11:06
`
`development work. Was that at the same time 09:11:08
`
`you were -- 09:11:09
`
` A Oh, no, no, much earlier, I was 09:11:10
`
`contacted to see if I was interested in 09:11:13
`
`accepting a position. 09:11:14
`
` Q That was before August 2018. 09:11:15
`
` A Well before. Yes. 09:11:24
`
` Q And do you recall what the reason 09:11:34
`
`was for when they contacted you in August 09:11:36
`
`2018? What was the request that was made of 09:11:38
`
`you? 09:11:41
`
` MR. THOMAS: Objection to 09:11:42
`
`form. Just -- go ahead. Objection to form. 09:11:42
`
` A Oh, the request was asking if I had 09:11:47
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 19
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`any time to do some consulting work. 09:11:49
`
` Q And what was the description of 09:11:55
`
`that consulting work? 09:11:56
`
` A At the time, he did not give me any 09:12:00
`
`description of the consulting work. 09:12:02
`
` Q And then were you put in contact 09:12:04
`
`with someone else at some point about that, 09:12:06
`
`about that work? 09:12:08
`
` A Again, the initial contact was he 09:12:11
`
`asked me if I was interested in a position 09:12:13
`
`many years ago. Then in August of 2018, he 09:12:16
`
`contacted me to see if I had any time to do 09:12:19
`
`consulting work. 09:12:21
`
` Q With respect to these IPR 09:12:26
`
`petitions, correct? 09:12:26
`
` A Yes, yes. 09:12:28
`
` Q So who did you talk to -- who did 09:12:29
`
`you talk to next relating to these IPR 09:12:30
`
`petitions? 09:12:32
`
` A Several weeks later, I had a 09:12:34
`
`contact from Chris Curfman from -- 09:12:36
`
` Q From the petitioner's law firm? 09:12:42
`
` A From the petitioner's law firm. 09:12:44
`
` Q And is your consulting agreement 09:12:54
`
`with Prollenium or is it with the law firm? 09:12:55
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` A My current one is with Prollenium. 09:12:59
`
` Q What is -- what are you charging 09:13:04
`
`them for your consulting work? 09:13:06
`
` A For this routine type of work is 09:13:10
`
`$500 per hour. 09:13:11
`
` Q And how much have you billed 09:13:16
`
`Prollenium to date? 09:13:20
`
` A I don't know exactly, but I -- I 09:13:21
`
`believe I billed them for approximately 100 09:13:23
`
`hours since that time. 09:13:26
`
` Q Have you been -- have you been paid 09:13:33
`
`for that time? 09:13:35
`
` A Yes. 09:13:35
`
` Q Now, who wrote your declarations in 09:13:38
`
`these IPR petitions? 09:13:41
`
` A I wrote the declarations. 09:13:42
`
` Q The attorneys didn't write it for 09:13:44
`
`you? 09:13:45
`
` A Well, I basically prepared them 09:13:48
`
`myself. 09:13:52
`
` Q So you on your own computer sat 09:13:53
`
`there and typed the words out; is that right? 09:13:54
`
` A Well, with assistance. 09:13:56
`
` Q And -- 09:13:58
`
` A But basically my words. 09:13:58
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 21
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` Q Okay. 09:14:00
`
` And who assisted you in that? 09:14:00
`
` A I guess from some standpoint, some 09:14:08
`
`assistance from the law firm. 09:14:10
`
` Q But if they had typed something 09:14:21
`
`that you didn't agree with, you would have -- 09:14:22
`
`you would have changed that, right? 09:14:24
`
` A I would have changed that. 09:14:26
`
` Q Right. 09:14:27
`
` If there's something in there 09:14:28
`
`that's a misrepresentation, you would have 09:14:29
`
`changed it. 09:14:31
`
` A Yes. 09:14:32
`
` Q If there was anything in there from 09:14:32
`
`a scientific standpoint, right, that you had 09:14:34
`
`concerns about, you would have changed it? 09:14:37
`
` A Yes. 09:14:38
`
` Q Did you -- besides the attorneys, 09:14:42
`
`did you speak with anyone else relating to 09:14:43
`
`the opinions that are contained in your 09:14:45
`
`declarations? 09:14:49
`
` A No. 09:14:50
`
` Q So what did you do to prepare for 09:14:58
`
`this deposition? 09:14:59
`
` A Reviewed prior art that I was aware 09:15:00
`
`Veritext Legal Solutions
`866 299-5127
`
`Page 22
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`of with technical legal -- with respect to 09:15:05
`
`FDA documentation and files, reviewed patents 09:15:10
`
`myself, many publications. 09:15:16
`
` Q And did you meet with anyone in 09:15:23
`
`preparation for your deposition? 09:15:24
`
` A Well, we had a meeting yesterday, 09:15:27
`
`just a brief -- a meeting yesterday. 09:15:32
`
` Q And that was with Mr. Thomas? 09:15:34
`
` A Yes. 09:15:36
`
` Q And were others available by phone? 09:15:36
`
` A Yes. 09:15:39
`
` Q And who was -- who was available by 09:15:39
`
`phone? Who joined by phone, if you remember? 09:15:41
`
` A There were -- there were two other 09:15:46
`
`people by phone. John -- 09:15:48